This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Analysts' Actions: CVX GOOG MRK SCHW YHOO

Sandridge Energy (MPEL) was downgraded at Ladenburg Thalmann from buy to neutral. $7 price target. Company could deliver lower oil production in the Mississippian, Ladenburg Thalmann said.

Sempra Energy (SRE) was upgraded at J.P. Morgan to overweight. Company can continue to outperform in 2013, with Latin America and LNG as the main growth drivers, J.P. Morgan said.

St. Jude Medical (STJ) was upgraded at Credit Suisse from neutral to outperform. $48 price target. Left investor meeting with a more favorable outlook for Durata, Credit Suisse said.

Timken (TKR) was upgraded at Bank of America/Merrill Lynch to buy. Company is a well-run company that is leveraged to an eventual cyclical recovery, BofA/Merrill said.

Wesco International (WCC) was downgraded at UBS to neutral from buy. $75 price target. Few catalysts in the near term, UBS said.

Wal-Mart (WMT) was downgraded at J.P. Morgan from overweight to neutral. $75 price target.

Western Union (WU) was upgraded at Deutsche Bank from hold to buy. $19 price target. Market is setting up well for a company turnaround, Deutsche said.

Yahoo! (YHOO - Get Report) was upgraded at Stifel Nicolaus from hold to buy. $25 price target. Alibaba and Yahoo Japan are rising in value, Stifel Nicolaus said.

STOCK COMMENTS / EPS CHANGES

AbbVie (ABBV) numbers raised at Jefferies. Shares of ABBV now seen reaching $45, Jefferies said. Estimates also raised on Humira continues to squeeze the bears. Buy rating.

Cisco Systems (CSCO) numbers raised at Oppenheimer. Shares of CSCO now seen reaching $24, Oppenheimer said. Estimates also raised on solid checks. Outperform rating.

Deckers Outdoor (DECK) numbers raised at Jefferies. Shares of DECK now seen reaching $60, Jefferies said. Estimates also raised on solid online trends and store checks. Buy rating.

Emerson (EMR) numbers raised at Oppenheimer. Shares of EMR now seen reaching $63, Oppenheimer said. Estimates also raised on recovery of premium. Perform rating.

FedEx (FDX) added to US 1 List at BofA/Merrill. FDX was placed on the US 1 list, Bank of America/Merrill Lynch said. Company is seeing positive volume trends and cutting costs. $122 price target.

Las Vegas Sands (LVS) numbers raised at Morgan Stanley. Shares of LVS now seen reaching $60, according to Morgan Stanley. Estimates also increased, given stronger growth in Macau. Overweight rating.

LyondellBasell (LYB) numbers raised at Jefferies. Shares of LYB now seen reaching $70, Jefferies said. Estimates also raised on favorable 2013 backdrop. Buy rating.

National Oilwell Varco (NOV) numbers lowered at Jefferies. Shares of NOV now seen reaching $86, Jefferies said. Estimates also lowered on longer- term rig tech conservatism. Buy rating.

Newell Rubbermaid (NWL) target raised at Oppenheimer to $27, Oppenheimer said. Game plan on track. Outperform rating.

PetSmart (PETM) added to US 1 List at BofA/Merrill. $85 price target. Company is leveraged to a favorable macro backdrop.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
CVX $104.73 -0.41%
GOOG $575.33 0.34%
MRK $57.98 0.17%
SCHW $30.21 1.14%
YHOO $44.16 0.39%

Markets

DOW 18,135.72 +38.82 0.21%
S&P 500 2,101.04 +2.51 0.12%
NASDAQ 4,982.8090 +15.6680 0.32%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs